Back to Search Start Over

Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases.

Authors :
Tan WL
Ng QS
Lim C
Tan EH
Toh CK
Ang MK
Kanesvaran R
Jain A
Tan DSW
Lim DW
Source :
BMC cancer [BMC Cancer] 2018 Dec 24; Vol. 18 (1), pp. 1288. Date of Electronic Publication: 2018 Dec 24.
Publication Year :
2018

Abstract

ᅟ.

Details

Language :
English
ISSN :
1471-2407
Volume :
18
Issue :
1
Database :
MEDLINE
Journal :
BMC cancer
Publication Type :
Academic Journal
Accession number :
30583726
Full Text :
https://doi.org/10.1186/s12885-018-5215-7